CLL/SLL
Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In patients who received prior chronic lymphocytic leukemia/small lymphocytic lymphoma-directed therapy but require ...
MARCH 10, 2025
Key Treatment Principles and Recent Updates In the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia is a lymphoproliferative disorder characterized by the accumulation of circulating ...
APRIL 10, 2024
FDA Approves Calquence for CLL and SLL
The FDA granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with ...
NOVEMBER 21, 2019
Venclexta Approved for Treatment of Previously Untreated CLL/SLL
The FDA approved venetoclax (Venclexta, AbbVie/Genentech) for the treatment of adults with chronic lymphocytic ...
JUNE 4, 2019
FDA Approves Imbruvica With Gazyva for First-Line CLL Treatment
The labeling for ibrutinib (Imbruvica, Pharmacyclics/Janssen) has been expanded to include use with obinutuzumab ...
FEBRUARY 4, 2019